Roche is on a roll: For the second time in less than a year, the company has scored FDA clearance for a pair of assays that can be used together to help spot signs of Alzheimer’s disease. The duo ...
Katharina Stoeck; Pascual Sanchez-Juan; Joanna Gawinecka; Alison Green; Anna Ladogana; Maurizio Pocchiari; Raquel Sanchez-Valle; Eva Mitrova; Theodor Sklaviadis ...
OTTAWA, Ontario — Looking for Alzheimer’s disease (AD) biomarkers in plasma instead of cerebrospinal fluid (CSF) is a simpler form of screening individuals for AD pathology and could result in earlier ...
This article was produced in partnership with the Davos Alzheimer’s Collaborative by Scientific American Custom Media, a division separate from the magazine’s board of editors. Henry, a carpenter in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results